AstraZeneca's lung cancer treatment fails to meet main goal [Reuters]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Reuters
AstraZeneca's lung cancer treatment fails to meet main goal (Reuters) - AstraZeneca Plc said on Tuesday its combo treatment for a form of lung cancer failed to meet the main goal of improving overall survival in patients in a late stage study, its second such setback in less than a month. The study tested the combination of its two drugs, Imfinzi and tremelimumab, as a first-line treatment in patients with extensive-stage small cell lung cancer, the company said. The safety and tolerability of the drugs were consistent with the known safety profiles of these medicines, the British drugmaker said. Earlier this month, Imfinzi and tremelimumab as a combo treatment for a form of bladder cancer also failed to meet the main goal of a late-stage study. Imfinzi is also being tested in a separate late stage study in certain patients with a form of lung cancer for which data is expected in 2021, AstraZeneca said. The drugs belong to an immunotherapy class of treatments, which strengthen the bod
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024 [Yahoo! Finance]Yahoo! Finance
- United States Non-small Cell Lung Cancer Digital Marketing Analysis Report 2023: Merck's Keytruda.com Achieved the Highest Total Traffic, Followed by BMS's Opdivo.com and AstraZeneca's Imfinzi.com [Yahoo! Finance]Yahoo! Finance
- Prescient Healthcare Group Appoints Two New Members to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Eosinophilic Esophagitis Pipeline Research 2024 [Yahoo! Finance]Yahoo! Finance
- For my beloved family, I leave you my.....fridge freezer! New research from Beko reveals the strangest items that are passed on [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/8/24 - Form 6-K
- AZN's page on the SEC website